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INTRODUCTION
Managing the comfort of children in the pediatric inten-
sive care unit (PICU) is one of the most difficult challenges
facing pediatric staff. These critically ill children are placed
in an unfamiliar and unpredictable environment, where visual
and auditory stimuli are excessive, painful stimuli are frequ-
ent, and sleep disturbances are common (1, 2). Sedation is
an essential tool in maintaining an optimal level of comfort
and safety for critically ill patients (3). Excessive sedation,
however, can lead to prolonged mechanical ventilation, ven-
tilator-associated pneumonia or lung injury, or neuromuscu-
lar disorders. By contrast, too little sedation can lead to inter-
ference with effective mechanical ventilation, myocardial and
cerebral ischemia, and potentially dangerous outcomes such
as self-extubation or removal of other mechanical devices (4).
Although clinical tools are available to assess and monitor
the degree of sedation in individual patients (5), most of them
have limitations in children. However, the COMFORT scale
has been validated in critically ill children (6).
In adults, there is increasing evidence that protocol-direct-
ed sedation of intubated patients can reduce the duration of
mechanical ventilation, the length of stay in the intensive
care unit (ICU) and hospital, and tracheostomy rates, and
can enhance the quality of sedation with reduced drug costs
(7-9). However, few studies have evaluated the effects of seda-
tion practices on clinical outcomes in children. We therefore
sought to identify whether protocol-directed sedation with
the COMFORT scale in critically ill children could affect
clinical outcomes, including duration of mechanical ventila-
tion, length of stay in the ICU, total amount and duration
of sedatives, and withdrawal symptoms.
MATERIALS AND METHODS
The study was conducted at the PICU (22 beds) of Asan
Medical Center (AMC), Seoul, Korea. Patients were eligible
if they were intubated, received mechanical ventilation, and
required sedation through continuous intravenous infusion
for longer than 48 hr. Patients who were admitted to the
PICU after surgery, resuscitated from cardiac arrest, trans-
ferred from an outside institution where sedatives had already
been administrated, or had abnormal neurological deficits
were excluded. The PICU sedation protocol of AMC (Fig. 1)
was developed prior to this study, and PICU physicians were
encouraged to adhere to this protocol during the study peri-
od. During the 12-month period (July 2003-June 2004),
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The Efficacy of the COMFORT Scale in Assessing Optimal Sedation
in Critically Ill Children Requiring Mechanical Ventilation 
Sedation is often necessary to optimize care for critically ill children requiring mechan-
ical ventilation. If too light or too deep, however, sedation can cause significant ad-
verse reactions, making it important to assess the degree of sedation and maintain
its optimal level. We evaluated the efficacy of the COMFORT scale in assessing
optimal sedation in critically ill children requiring mechanical ventilation. We com-
pared 12 month data in 21 patients (intervention group), for whom we used the pedi-
atric intensive care unit (PICU) sedation protocol of Asan Medical Center (Seoul,
Korea) and the COMFORT scale to maintain optimal sedation, with the data in 20
patients (control group) assessed before using the sedation protocol and the CO-
MPORT scale. Compared with the control group, the intervention group showed
significant decreases in the total usage of sedatives and analgesics, the duration
of mechanical ventilation (11.0 days vs. 12.5 days) and PICU stay (15.0 days vs.
19.5 days), and the development of withdrawal symptoms (1 case vs. 7 cases).
The total duration of sedation (8.0 days vs. 11.5 days) also tended to decrease.
These findings suggest that application of protocol-based sedation with the COM-
PORT scale may benefit children requiring mechanical ventilation. 
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one clinical pharmacist evaluated the level of sedation twice
daily in each patient using the COMFORT scale. The phar-
macist then discussed these results with an attending physi-
cian, who adjusted the infusion rates of sedatives to attain
an optimal COMFORT score, between 17 and 26 points.
Data were collected prospectively for the study period (inter-
vention group) and were compared with retrospective em-
piric therapy results during a 12-month period (July 2002-
June 2003) prior to the study (control group). The control
group consisted of patients admitted to the PICU who sat-
isfied the study inclusion criteria. Baseline demographic data,
PRISM III score, and reason for admission were recorded for
all patients. Clinical outcome variables, including duration
of mechanical ventilation, length of stay in the PICU, total
dose of sedatives, and occurrence of withdrawal symptoms
were compared between the two groups. Data were analyzed
on an intention-to-treat basis. Continuous variables were
analyzed using the Mann-Whitney rank sum test and pre-
sented as median values (with 25th and 75th percentiles).
Discrete variables were analyzed using chi-square analysis
with Fisher’s exact test or Pearson’s chi-square test, as appro-
priate. A p value less than <0.05 was considered statistically
significant, and all tests were based on two-sided hypothesis
testing. SPSS 12.0 K for Windows was used for all statisti-
cal analyses.
RESULTS
Demographic variables
A total of 53 patients were included in the study, 26 in the
intervention group and 27 in the control group. Five patients
in the intervention group and seven in the control group were
later excluded because their endotracheal tubes had been re-
moved or they died within the first 48 hr. Thus, 21 patients
in the intervention group and 20 patients in the control group
were included in the analysis. 
Demographic characteristics, PRISM III scores and diag-
nosis on ICU admission were similar in the two groups. The
type of continuously used sedatives did not differ significant-
ly between the two groups (Table 1). Neuromuscular block-
ing agents were infused continuously into nine patients in the
intervention group and eight in the control group (p=0.85).
Outcomes
The use of protocol-directed sedation with the COMFORT
scale in the intervention group was associated with signifi-
cant decreases, compared with the control group, in the mean
duration of mechanical ventilation (12.5 vs. 11.0 days, p=
0.04) and in the median length of stay in the PICU (15.0 vs.
19.5 days, p=0.04) (Table 2). The duration of sedation also
tended to be lower in the intervention group than in the con-
trol group (8.0 days vs. 11.5 days, p=0.053) (Table 2).
The overall development of withdrawal symptoms was sig-
Is the patient comfortable and at goal?
No
Reassess goal daily Rule out and correct reversible causes
Nonpharmacologic treatement
Pharmacologic treatment
For analgesia
For sedation
For delirium
Still need for NMB drugs
Weaning
Use modified Finnegan score Use COMFORT scale
Titrate and taper therapy to main-
tain goal; Consider daily wake-up;
Taper if >1 wk high-dose therapy,
and monitor for withdrawal
Adequate ventilation, tracheal tube 
satisfactory cardiac output optimized
full bladder, hunger, pyrexia
Fentanyl: IV Push 1 mcg/kg   Q5-15 min
infusion: 1-2 mcg/kg/hr (max: 3 mcg/kg/hr)
Midazolam: IV Push 0.1 mg/kg  Q5-15 min
infusion: 0.1-0.2 mg/kg/hr 
(max: 0.3 mg/kg/hr)
Lorazepam: IV Push 0.05-0.1 mg/kg  
Q6-8 hr
Chloral hydrate: PO 0.05-0.5 cc/kg (25-50
mcg/kg)  Q6-12 hr
Haloperidol: 0.01 mg/kg  Q24 h
Vecuronium: IV Push 0.1 mg/kg start 
infusion 0.05-0.15 mg/kg/hr
Atracurium: IV Push 0.5 mg/kg start infusion
0.3-0.36 mg/kg/hr (liver/renal dysfunction)
AND: dose down to fentanyl ≤ ≤3 mcg/kg/hr,
midazolam ≤ ≤0.3 mg/kg/hr
Dose reduction
If duration <5 days, 1/2 dose   Q24 hr
If duration ≥ ≥5 days, 10-25% Q12-
24 hr
YES
Fig. 1. Protocol of pediatric intensive care unit sedation at Asan
Medical Center. 
*Continuously infused sedatives.
ARDS, acute respiratory distress syndrome.
Clinical phenotypes p value
Intervention 
group 
(N=21)
Control 
group 
(N=20)
Age (months) 20.1±30.7 21.7±25.2 0.437
Sex (male/female) 8/13 9/11 0.282
Weight (kg) 8.1±4.9 10.1±5.6 0.071
PRISM III score 8.0±5.4 8.3±5.3 0.572
Diagnosis (n)
ARDS 7 8
Pneumonia 8 7
Bronchiolitis 5 4
Others 1 1
Sedatives*
Fentanyl 7 2
Midazolam 3 2
Fentanyl and midazolam 11 15
Ketamine 0 1
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nificantly lower in the intervention than in the control group
(1 vs. 7 patients, p=0.02). Mild withdrawal symptoms, mainly
presenting as loose stools and vomiting, was seen in one patient
in the intervention group and five in the control group; whereas
moderate withdrawal symptoms, presenting as tremors and
abnormal sleep patterns, were observed only in two control
group patients (Table 2). 
The total dose and maximum rate of continuous fentanyl
infusion and the maximum rate of continuous midazolam
infusion were significantly lower in the intervention group
than in the control group (Table 3). Except for ketamine, the
frequencies of intermittent doses of sedatives and neuromus-
cular blocking drugs were also significantly lower in the inter-
vention group than in the control group (Table 3).
DISCUSSION
Using a sedation protocol has been shown to be effective
in adjusting sedation at the ‘agitated’ end of the range, where-
as sedation scoring systems have been found effective in adjust-
ing sedation regimens at the opposite, or ‘over-sedated’, end
of the range (10). To navigate between agitation and over-
sedation, we integrated the COMFORT scale with the PICU
sedation protocol at AMC. 
In this study, we investigated and documented the effect
of the systematic use of a sedation protocol together with the
COMFORT scale in critically ill children requiring mechan-
ical ventilation. We found that this combination produced
better outcomes than the subjective judgment of a physician
alone. The duration of mechanical ventilation and the length
of stay in the ICU were significantly reduced in the interven-
tion group compared with the control group. These findings
are consistent with the results of previous studies in adults,
which demonstrated relationships between sedation practices
and the duration of mechanical ventilation (11-16). Our seda-
tion protocol was developed for patients requiring mechani-
cal ventilation. To determine optimal sedation level goals,
physicians were required to evaluate each patient’s causes of
restlessness and whether analgesics, sedatives or both were
required. In addition, a pharmacist and a nursing team were
employed to support these judgments. Our protocol provided
guidelines for choices of analgesics and/or sedatives, daily
reassessment, and dose adjustments. To our knowledge, no
previous studies have addressed the clinical effects of a seda-
tion protocol plus a sedation scoring system in children. Our
study results suggest that sedation protocols together with
the COMFORT scale can be safely implemented to improve
outcomes in critically ill children. 
We chose to use the COMFORT scale as a sedation scor-
ing system, because it has been demonstrated to be reliable
and has been validated as a descriptor of behavioral and phys-
iologic distress in critically ill children (17-20). In addition,
the COMFORT scale can measure not only the level of con-
sciousness but other parameters, including face grimacing,
muscle tone, physiological values and the level of agitation,
all of which are considered possible reflectors of tolerability
to the PICU environment. Furthermore, the COMFORT scale
was designed to be age-independent. 
The target range of the COMFORT score corresponding
to optimal sedation has been found to be between 17 and 26
points (21). We therefore used this range as our target goal,
and we regulated the infusion rate of sedatives for each patient
using the COMFORT score and the sedation protocol. Main-
tenance of the optimal level of sedation would therefore reduce
the amount of times patients were over-sedated or agitated,
thus reducing the amount and frequency of sedatives used.
We found that the doses of continuously infused sedatives
and their maximal infusion rates were lower in the interven-
tion group, as was the frequency of PRN or intermittently
*Modified Finnegan score (26); mild 0-7, moderate 8-11. 
PICU, pediatric intensive care unit.
Outcomes and 
withdrawal
p value
Intervention 
group 
(N=21)
Control 
group 
(N=20)
Median (interquartile range)
Duration of mechanical 11.0 (5.0-13.5) 12.5 (8.3-49.5) 0.04
ventilation (days)
Length of PICU stay (days) 15.0 (9.0-19.5) 19.5 (12.5-60.3) 0.04
Duration of sedation (days) 8.0 (3.5-13.0) 11.5 (8.0-33.3) 0.05
Withdrawal (n) 1 7 0.02
Mild* 15
Moderate* 02
Table 2. Comparison of outcomes and withdrawal between study
groups
Sedatives p value
Intervention 
group 
(N=21)
Control 
group 
(N=20)
Median (interquartile range)
Continuously used
Fentanyl
Total dose (mcg/kg) 204.0  495.5  0.02
(94.8-433.2) (280.3-835.1)
Maximum rate (mcg/kg/hr) 2.0 (1.4-2.5) 3.0 (2.5-3.0) <0.01
Midazolam
Total dose (mcg/kg) 37.5 (5.9-53.4) 55.0 (23.3-77.1) 0.08
Maximum rate (mcg/kg/hr) 0.2 (0.2-0.3) 0.3 (0.3-0.4) 0.01
PRN or intermittently
Used (n*)
Fentanyl 1.0 (1.0-2.0) 6.0 (1.5-14.5) 0.03
Midazolam 3.0 (2.0-5.0) 8.5 (5.0-8.5) <0.01
Lorazepam 4.0 (2.0-6.3) 13.0 (7.3-30.5) <0.01
Chloral hydrate 3.0 (1.0-6.3) 17.0 (5.5-25.0) <0.01
Ketamine 2.0 (1.5-4.0) 3.0 (2.0-11.0) 0.26
NMB drugs 2.0 (1.0-3.8) 9.0 (5.5-27.0) <0.01
Table 3. Comparison of sedatives used in the two study groups
*Frequency of use. NMB, neuromuscular blocking.696 H.-S. Jin, M.-S. Yum, S.-L. Kim, et al.
used sedatives.
Critically ill children who have required long-term seda-
tion for mechanical ventilation often experience withdrawal
syndromes after the termination of sedation, characterized
by agitation, anxiety, muscle twitching, sweating, and tremors
(22). Previous studies of protocol-based sedation, however,
have not evaluated withdrawal symptoms in these children
(3, 11, 12, 23, 24). Abstinence syndrome is commonly asso-
ciated with opiates and benzodiazepines, usually occurring
between 5 and 10 days after drug commencement (22). We
thus classified patients receiving more than 5 days of seda-
tive treatment into a risk group for withdrawal symptoms.
Patients in the risk group who required reduced doses of seda-
tives had their infusion rates reduced by 10-25% of the orig-
inal dose at an interval of 12-24 hr, with withdrawal symp-
toms monitored using a modified Finnegan score (25). We
found that both the incidence and severity of withdrawal
symptoms were reduced in our intervention group.
This study had several limitations. Since it was not a ran-
domized, controlled trial, and it used a historical control
group, methodologic weaknesses were present, and it was
difficult to quantify the effects of bias, including those asso-
ciated with improved general care between the sampling
periods of the two groups. However, there were no differences
in main strategies on ventilator care and attending staff, and
we believe the quality of general care was also similar. In
addition, our study evaluated small numbers of patients in
each group. Inclusion of larger numbers of patients would
require a longer study period, but that may have led to more
errors inherent in using historical controls. We therefore limit-
ed the study period to 12 months. Furthermore, we did not
evaluate the impact of sedation protocol on other outcomes,
such as the occurrence of unplanned extubation and ventila-
tor-associated pneumonia, and on treatment costs.
In conclusion, we found that the PICU sedation protocol
of Asan Medical Center, together with the COMFORT scale,
may be a safe and practical approach to treating pediatric pa-
tients receiving mechanical ventilation. This protocol decreased
the duration of mechanical ventilation, the length of stay in
the PICU, total dose of sedatives, and the incidence of with-
drawal symptoms. 
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